233 related articles for article (PubMed ID: 8549276)
1. Quinolone mode of action.
Hooper DC
Drugs; 1995; 49 Suppl 2():10-5. PubMed ID: 8549276
[TBL] [Abstract][Full Text] [Related]
2. Quinolone mode of action--new aspects.
Hooper DC
Drugs; 1993; 45 Suppl 3():8-14. PubMed ID: 7689456
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms of fluoroquinolone resistance: an update 1994-1998.
Piddock LJ
Drugs; 1999; 58 Suppl 2():11-8. PubMed ID: 10553699
[TBL] [Abstract][Full Text] [Related]
4. Quinolone resistance mutations in Streptococcus pneumoniae GyrA and ParC proteins: mechanistic insights into quinolone action from enzymatic analysis, intracellular levels, and phenotypes of wild-type and mutant proteins.
Pan XS; Yague G; Fisher LM
Antimicrob Agents Chemother; 2001 Nov; 45(11):3140-7. PubMed ID: 11600369
[TBL] [Abstract][Full Text] [Related]
5. DNA gyrase and topoisomerase IV on the bacterial chromosome: quinolone-induced DNA cleavage.
Chen CR; Malik M; Snyder M; Drlica K
J Mol Biol; 1996 May; 258(4):627-37. PubMed ID: 8636997
[TBL] [Abstract][Full Text] [Related]
6. Mode of action of the new quinolones: new data.
Hooper DC; Wolfson JS
Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):223-31. PubMed ID: 1650698
[TBL] [Abstract][Full Text] [Related]
7. Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
Strahilevitz J; Robicsek A; Hooper DC
Antimicrob Agents Chemother; 2006 Feb; 50(2):600-6. PubMed ID: 16436716
[TBL] [Abstract][Full Text] [Related]
8. Cloning, expression, and enzymatic characterization of Pseudomonas aeruginosa topoisomerase IV.
Akasaka T; Onodera Y; Tanaka M; Sato K
Antimicrob Agents Chemother; 1999 Mar; 43(3):530-6. PubMed ID: 10049263
[TBL] [Abstract][Full Text] [Related]
9. DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of type II topoisomerases.
Strahilevitz J; Truong-Bolduc QC; Hooper DC
Antimicrob Agents Chemother; 2005 Dec; 49(12):5051-7. PubMed ID: 16304172
[TBL] [Abstract][Full Text] [Related]
10. Conjugation between quinolone-susceptible bacteria can generate mutations in the quinolone resistance-determining region, inducing quinolone resistance.
Pitondo-Silva A; Martins VV; Silva CF; Stehling EG
Int J Antimicrob Agents; 2015 Feb; 45(2):119-23. PubMed ID: 25262036
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the gyrB, parC, and parE genes of quinolone-resistant isolates and mutants of Edwardsiella tarda.
Kim MS; Jun LJ; Shin SB; Park MA; Jung SH; Kim K; Moon KH; Jeong HD
J Microbiol Biotechnol; 2010 Dec; 20(12):1735-43. PubMed ID: 21193831
[TBL] [Abstract][Full Text] [Related]
12. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
Akasaka T; Tanaka M; Yamaguchi A; Sato K
Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of action of and resistance to quinolones.
Fàbrega A; Madurga S; Giralt E; Vila J
Microb Biotechnol; 2009 Jan; 2(1):40-61. PubMed ID: 21261881
[TBL] [Abstract][Full Text] [Related]
14. Mode of action of fluoroquinolones.
Hooper DC
Drugs; 1999; 58 Suppl 2():6-10. PubMed ID: 10553698
[TBL] [Abstract][Full Text] [Related]
15. Mode of action of the quinolone antimicrobial agents: review of recent information.
Hooper DC; Wolfson JS
Rev Infect Dis; 1989; 11 Suppl 5():S902-11. PubMed ID: 2549608
[TBL] [Abstract][Full Text] [Related]
16. Mechanism of action of quinolones against Escherichia coli DNA gyrase.
Yoshida H; Nakamura M; Bogaki M; Ito H; Kojima T; Hattori H; Nakamura S
Antimicrob Agents Chemother; 1993 Apr; 37(4):839-45. PubMed ID: 8388200
[TBL] [Abstract][Full Text] [Related]
17. Dual targeting of DNA gyrase and topoisomerase IV: target interactions of heteroaryl isothiazolones in Staphylococcus aureus.
Cheng J; Thanassi JA; Thoma CL; Bradbury BJ; Deshpande M; Pucci MJ
Antimicrob Agents Chemother; 2007 Jul; 51(7):2445-53. PubMed ID: 17502409
[TBL] [Abstract][Full Text] [Related]
18. Quinolone-resistant mutations of DNA gyrase increase sensitivity to acriflavine.
Funatsuki K; Tanaka R; Inagaki S; Konno H; Katoh K; Nakamura H
Biol Pharm Bull; 1998 Jul; 21(7):667-72. PubMed ID: 9703246
[TBL] [Abstract][Full Text] [Related]
19. Contribution of mutations in DNA gyrase and topoisomerase IV genes to ciprofloxacin resistance in Escherichia coli clinical isolates.
Bansal S; Tandon V
Int J Antimicrob Agents; 2011 Mar; 37(3):253-5. PubMed ID: 21236644
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of resistance to quinolones.
Cambau E; Gutmann L
Drugs; 1993; 45 Suppl 3():15-23. PubMed ID: 7689446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
